Raynaud's phenomenon as a presenting sign of ovarian adenocarcinoma.
Paira
S O
SO
D000230:Adenocarcinoma / Q000175:diagnosis* / Q000628:therapy; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D018394:CA-125 Antigen; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000175:diagnosis* / Q000628:therapy; D011928:Raynaud Disease / Q000175:diagnosis* / Q000628:therapy
D018394:CA-125 Antigen